Initial experience with lung cancer resection after treatment With T-cell checkpoint inhibitors Journal Article
| Authors: | Chaft, J. E.; Hellmann, M. D.; Velez, M. J.; Travis, W. D.; Rusch, V. W. |
| Article Title: | Initial experience with lung cancer resection after treatment With T-cell checkpoint inhibitors |
| Abstract: | T-cell checkpoint inhibitors targeting the programmed death receptor-1 (PD-1) and its ligand (PD-L1) have recently been approved for the treatment of metastatic non-small cell lung cancer (NSCLC), but their safety and efficacy as neoadjuvant therapy are still undefined. Autoimmune toxicities, notably pneumonitis, are a particular concern in the perioperative setting. This series of 5 cases describes for the first time the safety and technical issues relating to pulmonary resection after checkpoint inhibitor therapy. © 2017 The Society of Thoracic Surgeons |
| Journal Title: | Annals of Thoracic Surgery |
| Volume: | 104 |
| Issue: | 3 |
| ISSN: | 0003-4975 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2017-09-01 |
| Start Page: | e217 |
| End Page: | e218 |
| Language: | English |
| DOI: | 10.1016/j.athoracsur.2017.03.038 |
| PROVIDER: | scopus |
| PMCID: | PMC5572805 |
| PUBMED: | 28838509 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 October 2017 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work